Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06184971 · ClinicalTrials.gov registry record
Biliary Atresia Research Network Northeast
A clinical trial of Biliary Atresia, sponsored by Yale University.
- Recruiting
- Registry status
- 150
- Enrollment target
- 14
- Study locations
NCT06184971 is a study of Biliary Atresia that is actively recruiting participants, run by Yale University. The registered enrollment target is 150 participants, below the 554-participant average among 7 other Biliary Atresia trials with a reported enrollment target (73% lower). The trial reports 14 study locations across 6 states.
The verdict
NCT06184971, a study of Biliary Atresia, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 14
- Study locations
Study Summary
This is a multi-center retrospective chart review to compile a data repository of the management and outcomes of children with biliary atresia. Overall, investigators aim to evaluate which specific factors contribute to improved patient outcomes, to help guide potential improvements in patient care and resource utilization.
Conditions Studied
Study Locations (14)
Massachusetts
- Massachusetts General Hospital for Children - Boston
- Boston Children's Hospital - Boston
- Baystate - Springfield
- UMass Memorial Medical Center - Worcester
New York
- Albany Medical Center/Bernard & Millie Duke's Children's Hospital - Albany
- John R. Oishei Children's Hospital - Buffalo
- University of Rochester Medical Center/Golisano Children's Hospital - Rochester
- SUNY Upstate Medical University - Syracuse
Connecticut
- Connecticut Children's Medical Center - Hartford
- Yale University - New Haven
Maine
- Eastern Maine Medical Center - Bangor
- Maine Medical Center - Portland
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Rhode Island
- Rhode Island Hospital/Hasbro Children's Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-05-06 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06184971
The ClinicalTrials.gov registry entry for NCT06184971 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 554-participant average among 7 other Biliary Atresia trials with a reported enrollment target (73% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Biliary Atresia appearing as the primary indexed condition, and to 0 interventions.
NCT06184971 reports 14 study locations spanning 6 distinct geographic areas - top geographies include Massachusetts, New York, Connecticut.
Frequently Asked Questions
What is clinical trial NCT06184971 about?
NCT06184971 is a clinical study titled "Biliary Atresia Research Network Northeast". This is a multi-center retrospective chart review to compile a data repository of the management and outcomes of children with biliary atresia. Overall, investigators aim to evaluate which specific factors contribute to improved patient outcomes, to help guide potential improvements in patient care ...
What is the current status of trial NCT06184971?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2024-05-06. Estimated completion is 2025-12.
What conditions does trial NCT06184971 study?
This clinical trial studies the following conditions: Biliary Atresia.
Who is sponsoring clinical trial NCT06184971?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06184971 being conducted?
This trial has 14 study locations across Connecticut, Maine, Massachusetts, New Hampshire, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Biliary Atresia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Disease Pathways for Biliary Atresia
RECRUITING
-
Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
RECRUITING · Phase 1
-
A Prospective Database of Infants With Cholestasis
RECRUITING
-
Biliary Atresia Study in Infants and Children
RECRUITING
-
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
RECRUITING · Early Phase 1
-
Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.